Schmidinger, M., & Danesi, R. (2017). Management of Adverse Events Associated with Cabozantinib Therapy in Renal Cell Carcinoma. Oncologist.
Čikaški stil citiranjaSchmidinger, Manuela, i Romano Danesi. "Management of Adverse Events Associated With Cabozantinib Therapy in Renal Cell Carcinoma." Oncologist 2017.
MLA način citiranjaSchmidinger, Manuela, i Romano Danesi. "Management of Adverse Events Associated With Cabozantinib Therapy in Renal Cell Carcinoma." Oncologist 2017.
Upozorenje: Ovi citati možda nisu uvijek 100% točni.